NF2 Biosolutions
Accelerating Novel Therapies to cure NF2 -
830940046
2018
West Chester, PA 193826891
nf2biosolutions.org
nf2biosolutions
NF2BioSolutions
Podobné organizace
NEUROFIBROMATOSIS INC |
|
Neurofibromatosis Incorporated Northeast |
|
CureNFwithJack |
|
Nf Team Foundation |
|
THE GIORGIO FOUNDATION |
Podobné organizace global
THE NEUROFIBROMATOSIS ASSOCIATION |
|
MEF2C FOUNDATION |
|
JOANNA RUTH BELL FOUNDATION |
|
TUMOUR FOUNDATION OF BC |
|
Flicker of Hope Foundation Ltd |
More from West Chester
CHESTER COUNTY HOSPITAL FOUNDATION |
|
Friends of Marshall Square Park |
|
ITS YOUR FUTURE FOUNDATION |
|
CHESTER COUNTY'S CHILDREN INC |
|
JEFFREY THOMAS HAYDEN FOUNDATION |
Similar social media (5527)
The University Council for Educational Administration Inc5528 |
|
INNERCITY STRUGGLE5528 |
|
Managed Funds Association5528 |
|
Wayo Radio5528 |
|
Off Road United Foundation Inc5529 |
News
🎥 Missed the live webinar? The recording is now available! Learn about a groundbreaking AAV9-based gene therapy approach to treat NF2, presented by leading researchers in the field. ▶️ Watch the full recording now: 🔗 https://t.co/FDpOrE10aU https://t.co/0GkTe1uqIB (tw)
NF2 Awareness Month Is Over, But the Fight Isn’t 💙 May is behind us, but for those living with NF2, the challenges don’t end on June 1st, and neither does our mission. 👉 Donate today: Using Facebook: https://t.co/kP1qL4ddNE Using our webpage: https://t.co/OU97GAAilG https://t.co/J9dAPLzDfa (tw)
Poslední diskuze
Nearby
4.5
West Chester
About the organization
- G20 -
Accelerating Novel Therapy Research for Neurofibromatosis Type 2 Gene Therapy is changing the world of genetic diseases. Accelerating Novel Therapies to cure NF2 I am highly optimistic that this gene therapy strategy can represent an effective and safe therapy for patients with schwannomas whether associated with NF2 schwannomatosis or sporadic schwannomas. Message from Dr. Nicole Henwood founder and president of NF2 BioSolutions and mother of AJ diagnosed with NF2 Next Steps Our next steps include continuing to identify and sponsor leading gene cell and novel therapy labs to investigate the different therapy approaches that were discussed at our March 2019 consortium in Boston.
Birth Defects, Genetic Diseases
